1. Field of the Invention
The present invention relates to a medical device for delivering a dose of medicament by injection and having a shield system for preventing accidental needle sticks after use. More particularly, the present invention is directed to a syringe assembly including a safety shield system.
2. Description of the Related Art
Syringes used for the delivery of medicaments to patients are well known. Oftentimes syringes are prefilled with a dosage of a medicament or other substance by a pharmaceutical manufacturer and then distributed to end users such as health care professionals or patients for administration of the prefilled medicament. Such syringes typically include a cylindrical hollow barrel which may be formed of a glass or plastic material and which includes the medicament. One end of the barrel is fitted with a fixed or removable hollow needle, and the other end of the barrel receives a plunger having a stopper which is slidable with respect to the barrel for delivery of the medicament to the hollow needle, i.e., to urge the medicament toward and out of the needle. A syringe assembly, which typically includes the above-described components, is usually stored with a removable needle cover which protects the needle from damage during storage and handling. Prior to use, the needle cover is removed to expose the needle.
To prevent a syringe user and, in particular, a health care professional from inadvertent sticks by the needle after use of the syringe on a patient, the syringe assembly may incorporate a safety shield which forms a guard to cover the needle after use. Certain attributes to be considered in such syringe assemblies are that the shield should be intuitive and easy to use, should preferably provide consistent and reliable shield deployment, and should be operable with one hand. Other attributes are that such syringe assemblies require no change in current medicament delivery techniques, allow for dose adjustment, are autoclavable, and allow for the inspection of contents before and after activation of the shield. Moreover, the use of the shield must not detrimentally affect processing and loading of the syringe at the pharmaceutical company, the assembly (i.e., syringe assembly and safety shield) must be easy to manufacture, must prevent accidental activation, and must limit the possibility of incurring cosmetic or structural damages.
The present invention relates to a syringe incorporating a safety shield for covering the needle after administration of the dosage of medicament in the syringe. The safety shield is automatically activated upon full delivery of the medicament dosage in the syringe. As used herein, the term “medicament” is intended to refer to any drug substance, vaccine, or other liquid substance that is injected into a patient.
The object is met by a medical device for delivery of a dosage of medicament to a patient which includes a syringe assembly and a shield system. The syringe assembly includes a cylindrical barrel having a forward end and a rear end and a reservoir defined therebetween and within which a medicament may be held and from which the medicament may be expelled. The syringe assembly also includes a cannula or needle cannula (those terms being used interchangeably herein) provided at the forward end of the barrel and having a forward tip and a rear end in fluid communication with the reservoir for delivery of the medicament to the patient. The syringe assembly further includes a plunger rod having a stopper arranged at one end and a thumb pad or thumb press area arranged at the other end, the thumb pad being operable for receiving medicament delivery pressure for pressing the stopper of the plunger rod into the barrel and causing the stopper to move within the barrel to cause delivery of the medicament. The terms “thumb pad” and “thumb press area” designate a region coupled to or otherwise formed on an end of the plunger for receiving force applied to the plunger in an intended manner.
The shield system comprises a first shield connectable proximate the front end of the barrel, a second shield movable from a first position to a second position. The shield system also includes an urging member urging the second shield toward the second position, a retaining device for holding the second shield in the first position, and a release mechanism for releasing the retaining device after the stopper has been fully inserted into the barrel, wherein the forward tip of the needle cannula is at least partially exposed when the second shield is in the first position, and the forward tip of the needle cannula is covered by the second shield when the second shield is in the second position.
The second shield of the shield system is inserted telescopically in the first shield when the second shield is in the first position. Furthermore, the end of the second shield facing the barrel has a flange which interacts with the retaining device for holding the second shield in the first position. The retaining device may include a flexible arm arranged on the first shield having a retaining element for interaction with the flange. The release mechanism includes a tubular element arranged on the needle cannula and which is sealingly inserted with the needle cannula in an opening at the front of the barrel. The tubular element extends into the barrel such that the stopper contacts the tubular element at a contact position before the stopper is fully inserted in the barrel. When the stopper is moved passed the position of contact with the tubular element, the tubular element is pushed by the stopper as the stopper moves from the contact position to the fully inserted position. The tubular element is arranged to force the flexible arm radially outward when the tubular element is moved by the stopper to release the second shield.
The tubular element of the release mechanism includes a tubular portion and a flange portion arranged between two longitudinal ends of the tubular portion. The tubular portion is molded from a rigid material for supporting the needle cannula and the flange portion is molded from a flexible material having a flexibility sufficient to provide a seal at the front of the barrel. The flange portion may interact with the retaining device to release the second shield.
The urging member, which may, for example, comprise a spring, is arranged between the tubular element and the second shield. More specifically, the urging member is arranged between the flange portion of the tubular element and the second shield.
The first shield may comprise a lip at a front end thereof for retaining the flange of the second shield at the front end of the first shield when the second shield is released. The first shield may further comprise a locking device for locking the second shield in the second position. The locking device may include a flexible arm which allows the flange to pass the flexible arm as the second shield moves toward the second position and prevents the second shield from moving back toward the first position from the second position.
The second shield may comprise an annular bump between first and second ends thereof and the retaining device may comprise a lip arranged at a front end of the first shield which interacts with the annular bump. In this embodiment, the release mechanism may comprise a tubular element arranged on the needle cannula with a hub portion facing the barrel. The hub portion contacts the stopper at a contact position before the stopper reaches a fully inserted position. The tubular element and hub are then pushed by the stopper when the stopper moves to the fully inserted position in the barrel. The tubular element moves the second shield such that the annular bump is forced passed the lip to release the second shield when the stopper is moved to the fully inserted position.
The barrel of the syringe may comprise a cylindrical barrel portion for holding the medicament, and a front portion having a small cylinder and a transition portion between the small cylinder and the cylindrical barrel portion. The release mechanism includes a tubular element arranged on the needle cannula and is sealingly inserted with the needle cannula in an opening defined by the small cylinder. The first shield is connected on an outer surface of the small cylinder. The barrel of the syringe may be made from a plastic material or a glass material as is known in the art. Alternatively, the cylindrical barrel portion may be made from a glass material and the front portion may be made from a plastic material.
The object of the invention is also met by a shield system for connection to a syringe for preventing inadvertent needle sticks after use of the syringe. The shield system comprises a first shield connectable proximate a forward end of the syringe, a second shield movable from a first position to a second position, an urging member urging the second shield toward the second position, a retaining device for holding the second shield in the first position, and a release mechanism for releasing the retaining device from the first position.
The present invention allows one-hand operation and requires no change in current medicament delivery techniques. Since the entire shield assembly is arranged in front of the medicament holding portion of the syringe, the present invention allows dose adjustment, allows inspection of contents after activation of the shield, and the drug and scale on the syringe are visible to the end user. Activation of the shield does not interfere with administration of the dose because the shield is activated after the dose has been fully delivered.
Other objects and features of the present invention will become apparent from the following detailed description considered in conjunction with the accompanying drawings. It is to be understood, however, that the drawings are designed solely for purposes of illustration and not as a definition of the limits of the invention, for which reference should be made to the appended claims. It should be further understood that the drawings are not necessarily drawn to scale and that, unless otherwise indicated, they are merely intended to conceptually illustrate the structures and procedures described herein.
In the drawings, wherein like reference characters denote similar elements throughout the several views:
a is an enlarged cross-sectional view of alternative embodiment of a shield system according to the present invention;
The syringe assembly 2 comprises a generally cylindrical barrel 10 defining a reservoir 13 within which the medicament may be contained. The syringe assembly 2 further comprises and a needle cannula 18 having a forward tip 19 and a rear end 17 which is in fluid communication with the reservoir 13 and which is connected at a front end of the barrel 10 by a needle pusher 16 which will be explained in more detail below. The needle cannula 18 may comprise any sharp or blunt tubular device which is used for delivering a medicament to a patient. The barrel 10 may be made of any glass or plastic material suitable for holding a medicament. The syringe assembly 2 further comprises a plunger rod 12 having a first end inserted in the barrel 10. A stopper or piston 14 arranged on the first end of the plunger rod 12 is longitudinally movable with the plunger rod 12 within the barrel 10. A second end of the plunger rod 28 includes a thumb press area or thumb pad 15 which receives pressure from the user's thumb for pressing the piston 14 into the barrel 10 and for moving the piston 14 in and through the reservoir 13 for delivering the medicament.
The rear end of the barrel 10 includes a flange 11 which functions as a finger rest to facilitate the delivery of the medicament. Instead of flange 11, other finger rest configurations may be formed, such as two opposing projections or other flange configurations arranged at different areas along the barrel. The shield system 3 surrounds the external portion of the needle cannula 18 on the front end of the barrel 10. To protect the needle cannula and to protect users from being stuck by the needle prior to its intended use, a removable needle shield 27 (see
As shown in
As shown in
Referring to
Referring also to
Prior to use, the needle shield 27 is removed from the medical device 1 exposing the needle cannula 18 as shown in
The second shield 22 is prevented from being ejected out of, or detaching from, the first shield 20 by a lip 30 formed at the front end of the first shield 20 which engages flange 22a. Furthermore, additional flexible arms 28 are arranged just behind the lip 30 and function as a one-way guide for allowing the flange 22a of the second shield to pass as the second shield 22 is moved over the needle cannula 18, and for preventing the second shield 22 from moving back into the first shield 20. The medical device 1 may then be safely handled without inadvertent stabbing or sticking of the user from the now-used and contaminated needle cannula 18.
In an alternative embodiment shown in
In another embodiment shown in
a shows another alternative embodiment in which the lip 30′ comprises first and second sections 30a, 30b that are axially offset from each other. When the second shield 22 is pushed into the activated position, the flange 22a first contacts the first section 30a which causes the second shield to pivot about the initial point of contact at section 30a until another part of the flange 22a rests on the second section 30b (or until the shield 22 contacts the needle cannula), as shown in
A description of an exemplary usage of the medical device 1 of the present invention will now be provided. It should be understood by a person of ordinary skill in the art that the following description is provided as an illustrative and non-limiting example. The health care professional receives the inventive medical device 1 prefilled with a desired single dosage of a medicament. Immediately prior to use, the needle shield 27 is removed and the needle cannula 18 and forward tip 19 are exposed. The health care professional pierces the patient's skin with the forward tip 19 of the needle cannula 18 and depresses the thumb pad 15 to cause the plunger rod 12 and stopper 14 to move within the reservoir 13. As the plunger rod 12 and stopper 14 are caused to move into the reservoir, the medicament is caused to be expelled from the reservoir, through the needle cannula 18, and into the patient. When the medicament is completely expelled from the reservoir (i.e., the dose has been completely administered), additional pressure will then be applied to the thumb pad 15 (with or without the needle cannula 18 removed from the patient), to urge the plunger rod further into the barrel. This further movement causes the needle pusher 16 to release flange 22a from the channel 31 whereby the second shield 22 will then be deployed by the urging member 24 to a position covering the needle cannula tip 19. Once so-deployed, the lip 30 formed at the front end of the first shield 20 engages flange 22a of the second shield to maintain coupling between the first and second shields. The covering of the needle cannula tip 19 by the second shield prevents undesired and inadvertent exposure of the health care professional to the contaminated tip 19. The used medical device 1 may then be disposed of in a suitable sharps disposal container.
Thus, while there have shown and described and pointed out fundamental novel features of the invention as applied to a preferred embodiment thereof, it will be understood that various omissions and substitutions and changes in the form and details of the devices illustrated, and in their operation, may be made by those skilled in the art without departing from the spirit of the invention. For example, it is expressly intended that all combinations of those elements and/or method steps which perform substantially the same function in substantially the same way to achieve the same results are within the scope of the invention. Moreover, it should be recognized that structures and/or elements and/or method steps shown and/or described in connection with any disclosed form or embodiment of the invention may be incorporated in any other disclosed or described or suggested form or embodiment as a general matter of design choice. It is the intention, therefore, to be limited only as indicated by the scope of the claims appended hereto.
Number | Name | Date | Kind |
---|---|---|---|
4573976 | Sampson | Mar 1986 | A |
4631057 | Mitchell | Dec 1986 | A |
4737144 | Choksi | Apr 1988 | A |
4747831 | Kulli | May 1988 | A |
4795432 | Karczmer | Jan 1989 | A |
4813940 | Parry | Mar 1989 | A |
4985021 | Straw | Jan 1991 | A |
4998920 | Johnson | Mar 1991 | A |
5026356 | Smith | Jun 1991 | A |
5053018 | Talonn | Oct 1991 | A |
5061251 | Juhasz | Oct 1991 | A |
5151088 | Allison | Sep 1992 | A |
5156599 | Ranford | Oct 1992 | A |
5163918 | Righi | Nov 1992 | A |
5193552 | Columbus | Mar 1993 | A |
5197953 | Colonna | Mar 1993 | A |
5201708 | Martin | Apr 1993 | A |
5217437 | Talonn | Jun 1993 | A |
5242420 | Martin | Sep 1993 | A |
5246427 | Sturman | Sep 1993 | A |
5273541 | Malenchek | Dec 1993 | A |
5300040 | Martin | Apr 1994 | A |
5304149 | Morigi | Apr 1994 | A |
5308332 | Dillard, III | May 1994 | A |
5312372 | DeHarde et al. | May 1994 | A |
5336176 | Yoon | Aug 1994 | A |
5342309 | Hausser | Aug 1994 | A |
5342320 | Cameron | Aug 1994 | A |
5370628 | Allison | Dec 1994 | A |
5385555 | Hausser | Jan 1995 | A |
5389085 | D'Alessio | Feb 1995 | A |
5417660 | Martin | May 1995 | A |
5562626 | Sanpietro | Oct 1996 | A |
5651774 | Taranto | Jul 1997 | A |
5658254 | Reichenbach | Aug 1997 | A |
5681292 | Tober | Oct 1997 | A |
5713871 | Stock | Feb 1998 | A |
5735823 | Berger | Apr 1998 | A |
5769822 | McGary | Jun 1998 | A |
5800395 | Botich | Sep 1998 | A |
5800403 | Pressly | Sep 1998 | A |
5882342 | Cooper | Mar 1999 | A |
6017329 | Hake | Jan 2000 | A |
6077253 | Cosme | Jun 2000 | A |
6162197 | Mohammad | Dec 2000 | A |
6228054 | Dysarz | May 2001 | B1 |
6319233 | Jansen | Nov 2001 | B1 |
6432087 | Hoeck et al. | Aug 2002 | B1 |
6432088 | Huang et al. | Aug 2002 | B1 |
6440104 | Newby et al. | Aug 2002 | B1 |
6443929 | Kuracina | Sep 2002 | B1 |
6458101 | Hu | Oct 2002 | B1 |
6458105 | Rippstein et al. | Oct 2002 | B1 |
6461333 | Frezza | Oct 2002 | B1 |
6461362 | Halseth | Oct 2002 | B1 |
6475194 | Domici, Jr. | Nov 2002 | B1 |
6478780 | Shields | Nov 2002 | B1 |
6494863 | Shaw | Dec 2002 | B1 |
6511460 | Arnissolle | Jan 2003 | B1 |
6514229 | Huang | Feb 2003 | B1 |
6527742 | Malenchek | Mar 2003 | B1 |
6530903 | Wang | Mar 2003 | B1 |
6547762 | Botich | Apr 2003 | B1 |
6558357 | Hoeck | May 2003 | B1 |
6565540 | Perouse | May 2003 | B1 |
6569115 | Barker | May 2003 | B1 |
6569124 | Perouse | May 2003 | B1 |
6589209 | Dysarz | Jul 2003 | B1 |
6595954 | Luther | Jul 2003 | B1 |
6605073 | Pressly | Aug 2003 | B1 |
6817989 | Svendsen et al. | Nov 2004 | B1 |
20020065488 | Suzuki et al. | May 2002 | A1 |
20020193737 | Popovsky | Dec 2002 | A1 |
20020193746 | Chevallier | Dec 2002 | A1 |
20020193747 | Denolly | Dec 2002 | A1 |
20030023205 | Botich | Jan 2003 | A1 |
20030028171 | DeHarade | Feb 2003 | A1 |
20030036730 | Von Teichert | Feb 2003 | A1 |
20030050601 | Righi | Mar 2003 | A1 |
20030050607 | Gaagnieux | Mar 2003 | A1 |
20030078546 | Jensen | Apr 2003 | A1 |
20030083627 | Chen | May 2003 | A1 |
20030114799 | Cheikh | Jun 2003 | A1 |
20030144630 | Chang | Jul 2003 | A1 |
20030149403 | Barker | Aug 2003 | A1 |
20030149404 | Lehmann | Aug 2003 | A1 |
20040044312 | Svendsen et al. | Mar 2004 | A1 |
20040236281 | Popovsky | Nov 2004 | A1 |
Number | Date | Country |
---|---|---|
0 307 367 | Jun 1992 | EP |
0 680 767 | Nov 1995 | EP |
0 864 335 | Sep 1996 | EP |
0 740 942 | Nov 1996 | EP |
0 966 983 | Dec 1999 | EP |
1 066 848 | Jun 2000 | EP |
1 258 263 | Nov 2002 | EP |
1 260 242 | Nov 2002 | EP |
0 901 391 | Jan 2003 | EP |
0 963 213 | Jan 2003 | EP |
1 273 316 | Jan 2003 | EP |
1 281 410 | Feb 2003 | EP |
0 916 354 | Mar 2003 | EP |
1 287 842 | Mar 2003 | EP |
1 291 029 | Mar 2003 | EP |
1 291 030 | Mar 2003 | EP |
1 317 938 | Jun 2003 | EP |
0 984 804 | Jul 2003 | EP |
1 329 234 | Jul 2003 | EP |
0 941 134 | Aug 2003 | EP |
1 205 173 | Sep 2003 | EP |
1 205 173 | Sep 2003 | EP |
0 734 738 | Oct 2003 | EP |
1 049 503 | Oct 2003 | EP |
1 472 980 | Apr 2004 | EP |
2 830 764 | Apr 2003 | FR |
2 830 765 | Apr 2003 | FR |
2 282 069 | Mar 1995 | GB |
2001193714 | Dec 2002 | JP |
WO 0141841 | Jun 2001 | WO |
WO 0141841 | Jun 2001 | WO |
WO 0160435 | Aug 2001 | WO |
WO 0185238 | Nov 2001 | WO |
WO 02089878 | Nov 2002 | WO |
WO 02098480 | Dec 2002 | WO |
WO 02098494 | Dec 2002 | WO |
WO 02098494 | Dec 2002 | WO |
WO 03000322 | Jan 2003 | WO |
WO 03000323 | Jan 2003 | WO |
WO 03011378 | Feb 2003 | WO |
WO 03015852 | Feb 2003 | WO |
WO 03022335 | Mar 2003 | WO |
WO 03033059 | Apr 2003 | WO |
WO 03033060 | Apr 2003 | WO |
WO 03041766 | May 2003 | WO |
WO 03045476 | Jun 2003 | WO |
WO 03045480 | Jun 2003 | WO |
WO 03045481 | Jun 2003 | WO |
WO 03063934 | Aug 2003 | WO |
WO 03068297 | Aug 2003 | WO |
WO 03068298 | Aug 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20050096599 A1 | May 2005 | US |